Comparing efficacy of receiving different dosages of eptifibatide in bleeding after percutaneous coronary intervention in patients with myocardial infarction

BACKGROUND: Acute coronary syndrome (ACS) is a common condition that needs appropriate treatment like percutaneous coronary intervention (PCI). Glycoprotein IIb/IIIa inhibitors (GPI) like eptifibatide prevent procedural ischemic complications after PCI. Eptifibatide has increased the risk of bleedin...

Descripción completa

Detalles Bibliográficos
Autores principales: Shemirani, Hasan, Khosravi, Alireza, Eghbal, Ali, Amirpour, Afshin, Roghani, Farshad, Hashemi-Jazi, Seyed Mohammad, Pourmoghaddas, Ali, Heidari, Ramin, Sajjadieh, Amir, Sadeghi, Nahid, Sanei, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884730/
https://www.ncbi.nlm.nih.gov/pubmed/31819752
http://dx.doi.org/10.22122/arya.v15i4.1668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884730/
https://www.ncbi.nlm.nih.gov/pubmed/31819752
http://dx.doi.org/10.22122/arya.v15i4.1668

Ejemplares similares